high cbc strains

What is CBC and what is it for?

Lately, new applications are emerging for some components of the cannabis plant. Until a few years ago THC was the most studied compound, but over the last decade CBD has made a lot of headway.

Research on new medical applications for cannabinoids continues nowadays, and now it’s time for cannabis CBC.

⚠️ What is CBC ?

CBC stands for Cannabicromene, and is the third most abundant cannabinoid in cannabis plants. It was discovered in 1966, but it really hasn’t been studied that much so far.

CBC is a legal compound, it is usually found in concentrations of less than 0.5% in cannabis resin. It is not psychoactive, although it can have an impact on the kind of effect and seems to have very interesting medicinal properties.

Image of CBC molecule*

🧐 CBC Benefits

The most interesting thing about this component is that it does not act only on CB1 and CB2 receptors like any other cannabinoid. It seems that the effect of Cannabicromene also activates TRPV1 and TRPA1 receptors, the channels through which pain signals are sent among others.

This may have many applications in the near future, as CBC can be a great substitute for today’s pain medications, which often have many adverse side effects.

👾 CBC Applications

International medical and scientific community has recently focused on this compound. Some studies seem to confirm that Cannabicromene is very useful for treating ailments or diseases like these:

  1. Chronic pain, stimulates pain relief networks
  2. Inflammations, especially combined with THC, CBD or both
  3. Stress, CBC produces relaxation
  4. Depression, clear improvement in mental illness
  5. Antibacterial, very effective against lethal bacteria such as E. coli
  6. Stimulates growth of new cells
  7. Anti-acne, reduces the production of sebaceous glands
  8. Delays degeneration in brain diseases
  9. Neurogenerator, promotes growth of nerve tissue

🎯 CBC Products on the market

Cannabicromene-rich hemp products are sold in some countries. They are now starting to be used for pain treatment among other things, although they are not yet as widespread as CBD products.

Cartridges with CBC for recharging the vaporizer are one of the best sellers, although distilled with more than 10% concentration, isolated with almost 100% CBC and less than 0.3% THC, pills with high CBC values and especially CBC oil, also succeed.


This is the flagship product, as with other cannabinoids, oil is the most consumed format. This is because of its versatility, as it can be taken directly by drops, or by refilling pills with the dose we need.

These oils are usually produced from industrial hemp, and in addition to CBC they contain CBD, CBG and CBN in different proportions. The synergy created by the action of all these compounds together makes CBC oil more effective in uses such as seizures, convulsions, pain or stress among others.

In the near future, products with CBD + CBC + certain terpenes will surely come out to treat specific ailments, as they are proving to be more effective than the great majority of current medicines.

Image of a CBC-rich oil bottle*


To date Cannabidiol has proven to have more therapeutic applications than Cannabicromene, but it has also been studied much more. CBD acts on the endocannabinoid system and has multiple medicinal properties. CBC has been much less researched, but recent studies are very encouraging, as they have shown that in addition to activating the same receptors as other cannabinoids, they also act on the networks responsible for regulating pain in animals.

✅ CBC-rich varieties

The strains with the highest CBC content found so far are Landrace genetics from northern India. They are not high levels, never reach 3%, but it always goes with CBD or CBG, so it can have great therapeutic value.

As for modern hybrids, we have not yet seen any that reach even 1% of CBC. Within current cannabis varieties, Birthday Cake has a respectable 0.7% and 3 Kings almost 0.5%.

🚀 Conclusion

Cannabicromene may be one of the most important cannabinoids in the future, as it may become the best treatment for pain. We will keep an eye on all the news to be able to inform you as much and as well as possible, but please do us a favor and share this article. Thank you!

Do you know what Cannabicromene is? Do you know what its benefits and medicinal applications are? In this post we reveal everything…

Cannabichromene (CBC): The Third Most Common Cannabinoid

CBC is the third most prominent cannabinoid, but not much is known about it. What is known is that it apparently plays a key role in neurogenesis, pain reduction, and lessening of inflammation.

Cannabichromene (CBC) is one of the lesser-known cannabinoids. At least at the moment. Very little research has been conducted on this compound, although it is believed to be non-psychoactive.

First discovered in 1966, CBC is structurally similar to other cannabinoids. However, it is also believed to play a key role in cannabis’ anti-inflammatory and analgesic properties.


CBC directly interacts with CB1 and CB2 receptors throughout the body and brain. However, it also works with other receptors, specifically TRPA1 and TRPV1 [1] . These channels, like the endocannabinoid system (ECS) comprised of cannabinoid receptors, link throughout the body. They play a key role in pain and inflammation transmission signals sent to other regions of the body.

Why? “TRP” stands for “transient receptor potential channels” This means that they are essentially the SOS channel over which signals about pain and inflammation are sent.

Even more interesting? CBC is one of the most prevalent, if still largely unresearched cannabinoids. It is also the third most abundant cannabinoid found in generalised plant samples, behind THC and CBD.


What this means for how cannabinoids will be combined is huge. Perhaps these “extra,” non-psychoactive cannabinoids like CBC act like additional keys or codes. The ECS may in fact be the master regulator. However, side “channels” as it were – such as other switching networks in the body, may also be stimulated by the additional cannabinoids in the cannabis plant.

Confused? Think about the human body like an electrical system or a series of canals. The ECS appears to be one “channel” with cannabinoid receptors. Yet, cannabis also appears to have the ability to send signals into other “channels” too. It may well be that cannabinoids stimulate the ECS the most, but they can also access different receptors as well.

If that is true, then CBC in particular may become a “specialty” cannabinoid all its own. Indeed, it may eventually even be employed to treat or benefit a specific class of health conditions. This in and of itself is a revolutionary way to think not only about CBC, but an entire network of other potentially beneficial cannabinoids as well.


Cannabichromenic acid, or CBCA, is the parent molecule of CBC and is one of the three primary cannabinoids formed from cannabigerolic acid (CBGA). CBGA is one of the first cannabinoid produced by cannabis plants and, over time, is broken down by specific enzymes to form THCA, CBDA, and CBCA. Eventually, when cannabis is exposed to heat and UV light during the drying, curing, and smoking/vaping/cooking processes, CBCA is broken down further into CBC and CBL, and CBLA.

To date, little research has looked specifically at the effects of CBCA on the body and it was believed that it does not have therapeutic properties of its own. Nowadays, scientists think it is possible that CBCA exerts anti-inflammatory, antimicrobial and analgesic effects.


Apart from generalities of “inflammation” or “pain,” CBC is already starting to be applied to other conditions. New research published last year by the Journal for Experimental Dermatology found that CBC may be good for acne treatment. Why? it appears to reduce the production of sebum by sebaceous glands, while also reducing the impact of arachidonic acid on the skin and glands.

It is not known, thanks to lack of research and data, how exactly CBC can manage pain. However, it is clear that it can and most likely will be used to do so in future trials and treatments. This begins with any movement disorder where inflammation is also a feature, such as arthritis.

Even more thrilling? CBC appears to promote neurogenesis, the growth of nervous tissue. It also may be a key cannabinoid that impacts or retards cell degeneration in conditions like depression, Alzheimer’s, Parkinson’s, Huntington’s, and motor neuron disease.

The properties of this cannabinoid are no doubt intriguing. Even with few human trials to back it up, CBC is already making waves.

1. CBC and neurogenesis. A mouse study [2] published in 2013 suggests that CBC can positively encourage new cell growth.

2. CBC may be good for reducing chronic stress and depression. A University of Mississippi study found rat subjects [3] treated with CBC to perform better on stress tests.

3. CBC is an anti-inflammatory. [4] A 2010 study found CBC to initiate anti-inflammatory benefits all on its own. However, it also appears to work better when combined with THC and CBD. The combination of all three was more effective than the combination of just the other two.

4. This little cannabinoid might have a huge impact on pain. A 2011 study [5] found that CBC stimulated pain-relieving networks in animal models.

5. CBC has clear anti-bacterial properties, which have been identified for at least thirty years. Studies in the 1980’s even indicate that CBC might be directly impactful against deadly bacterial killers like E. coli [6] .


Research dating back to the 1970’s shows that landrace strains from India carry a high level of CBC. In fact, in these samples, CBC appears to be more abundant than CBD. CBC is also found in higher levels in younger plants. It degrades naturally to another cannabinoid called cannabicyclol in the presence of heat and light. These days, however, most crops are optimised for THC and CBD content. In fact, a 2013 study analysed the cannabinoids of one of Europe’s most widely distributed medical strains called Bediol. Both CBC and CBN – another “minor” cannabinoid, were both identified as trace elements.

CBC is increasingly being seen as a critical player in the cannabinoid medicine chest. This starts with its ability to potentially treat pain and inflammation.